Persistent URL of this record https://hdl.handle.net/1887/113086
In Collections
This item can be found in the following collections:
![Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report
- All authors
- Armstrong, T.S.; Bishof, A.M.; Brown, P.D.; Klein, M.; Taphoorn, M.J.B.; Theodore-Oklota, C.
- Date
- 2016-03-31
- Journal
- Neuro-Oncology
- Volume
- 18
- Pages
- 1 - 12